MyFinsight
Home
About
Contact
tars: the income statement
Download
Download image
Comprehensive loss
-$12,335K
(46.13%↑ Y/Y)
Unrealized gain (loss) on
marketable securities and...
$250K
(-52.11%↓ Y/Y)
Other income
(expense), net
$98K
(46.27%↑ Y/Y)
Interest income
$4,114K
(-0.15%↓ Y/Y)
Net loss
-$12,585K
(46.26%↑ Y/Y)
Total other income
(expense), net
$1,944K
(11.60%↑ Y/Y)
Product
$118,697K
Interest expense
$2,268K
(-7.24%↓ Y/Y)
Loss from operations
before other income...
-$14,529K
(42.26%↑ Y/Y)
Total revenues
$118,697K
(146.68%↑ Y/Y)
Total operating
expenses
$133,226K
(81.80%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)